Gout and hyperuricemia

Current Opinion in Rheumatology

Volumn 14, Issue 3, 2002, Pages 281-286

  Wortmann, Robert L ^a  

^a University of Oklahoma Tulsa College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; ANTILIPEMIC AGENT; COLCHICINE; CORTICOTROPIN; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; OXIPURINOL; PROBENECID; SALICYLIC ACID; SULFINPYRAZONE; URATE OXIDASE; URICOSURIC AGENT;

AFRICA; ALCOHOL CONSUMPTION; ASIA; CARDIOVASCULAR DISEASE; DIET THERAPY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; GASTROINTESTINAL SYMPTOM; GENETICS; GOUT; GUILLAIN BARRE SYNDROME; HUMAN; HYPERTENSION; HYPERURICEMIA; INSULIN RESISTANCE; NEUROMUSCULAR DISEASE; OBESITY; PRIORITY JOURNAL; REVIEW; RHABDOMYOLYSIS; SYMPTOMATOLOGY; URIC ACID URINE LEVEL;

AFRICA; ARTHRITIS, GOUTY; ASIA; CARDIOVASCULAR DISEASES; DIET THERAPY; GOUT; HUMANS; PREVALENCE; URIC ACID;

EID: 0036231531     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200205000-00015     Document Type: Review

References (41)

1. Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen
2. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study
3. Hyperuricemia and gout in Taiwan: Results from the nutritional and health survey in Taiwan
4. Risk factors for gout in Togolese patients
5. Clinical manifestations of Korean female gouty patients
6. Gouty arthritis in Australian Aborigines
7. Prevalence of rheumatic diseases in a rural population in western India: A WHO-ILAR COPCORD study
8. Hyperuricemia in Saudi Arabia
9. Quiz case: Atypical gouty arthritis
10. An unusual systemic presentation of gout
11. Isolated gouty tophus of a tibial sesamoid of the foot
12. Intradermal tophaceous gout
13. Flexor tendonitis and median nerve compression caused by gout in a patient with rheumatoid arthritis
14. Laryngeal manifestation of gout: A case report of a subglottic gout tophus
15. Tophaceous gout of the spine mimicking epidural infection: Case report and review of the literature
16. Spinal cord compression: An unusual neurologic complication of gout
17. Acute paraplegia in a patient with spinal tophi: A case report
18. Gender differences in the relationships of serum uric acid with fasting serum insulin and plasma glucose in patients without diabetes
19. Increase visceral fat accumulation further aggravates the risks of insulin resistance in gout
20. Decreased activities of lipoprotein lipase and hepatic triglryceride lipase in patients with gout
21. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers
22. Biomechanical profile of idiopathic uric acid and nephrolithiasis
23. Spot urine uric acid to creatinine ratio used in the estimation of uric acid excretion in primary gout
24. When, why, and how should we quantify the excretion rate of urinary uric acid?
25. Biochemical profile of idiopataic uric acid nephrolithiasis
26. Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: A pilot study
27. Gout: Diet and uric acid revisited
28. Self-treatment for gout
29. Corticotropin for acute management of gout
30. Current aspects of colchicine therapy classical indications and new therapeutic uses
31. Colchicine toxicity. Distinct morphologic findings in gastrointestinal biopsies
32. Colchicine induced rhabdomyolysis
33. Effect of low dose daily aspirin on serum urate levels and urinary excretion in patients receiving probenecid for gouty arthritis
34. Effect of fenofibrate on plasma concentration and urinary excretion of purine bases and oxypurinol
35. The optimal use of allopurinol: An audit of allopurinol use in South Auckland
36. Effects of hemodialysis on advance bony tophi in a tophaceous gout patient with chronic renal failure
37. Guillain-Barre syndrome and allopurinol-induced hyperuricemia
38. How should hyperuricemia be treated in a patient with allopurinol hypersensitivity?
39. Difficult gout and new approaches for control of hyperuricemia in the allopurinol allergic patient
40. Efficacy and safety of desensitization to allopurinol following cutaneous reactions